Avidity Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Avidity Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q3 2024.
  • Avidity Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $14.1M, a 43.5% increase year-over-year.
  • Avidity Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $47.1M, a 31.9% increase year-over-year.
  • Avidity Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $38.2M, a 40.8% increase from 2022.
  • Avidity Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $27.1M, a 59.1% increase from 2021.
  • Avidity Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $17.1M, a 296% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $47.1M $14.1M +$4.27M +43.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $42.8M $12.8M +$3.36M +35.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $39.4M $10.3M +$1.2M +13.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $38.2M $9.85M +$2.54M +34.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $35.7M $9.82M +$2.73M +38.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $33M $9.45M +$2.95M +45.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $30M $9.1M +$2.87M +45.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $27.1M $7.31M +$2.79M +61.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $24.3M $7.09M +$2.54M +55.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $21.8M $6.51M +$2.22M +51.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $19.6M $6.24M +$2.54M +68.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $17.1M $4.52M +$2.64M +140% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $14.4M $4.55M +$3.25M +251% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $11.2M $4.29M +$3.6M +524% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $7.56M $3.7M +$3.25M +724% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $4.31M $1.88M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $1.3M +$1.27M +5791% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $687K +$671K +4194% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $449K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 $22K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $16K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.